The Rooney Heart Institute at NCH is the first in Florida to offer a groundbreaking solution for patients experiencing in-stent restenosis, a condition where scar tissue or plaque causes previously placed stents to narrow again, leading to recurring symptoms. After enduring multiple procedures and persistent issues, patient Richard Parent found relief with a new drug-coated balloon developed by Boston Scientific.
This innovative approach uses a balloon to push aside scar tissue and deliver a medication that significantly reduces the likelihood of future scar formation, offering an alternative to traditional bypass surgery. With faster recovery and improved outcomes, this cutting-edge technology represents a major advancement in cardiac care, providing new hope for patients like Parent. NCH’s leadership in adopting this solution highlights its commitment to pioneering patient care. Read More >
WINK covers NCH introduces advanced drug-coated balloon for treating in-stent restenosis.
